Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute stroke therapies

S U Brint1

  • 1Department of Neurology, University of Illinois at Chicago, USA.

Surgical Neurology
|November 1, 1996
PubMed
Summary
This summary is machine-generated.

Thrombolytic agents show promise for acute ischemic stroke treatment, with intravenous administration being most practical. Further research into fibrinolytic agents and other therapies may improve stroke outcomes and prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The display of photographic-quality images on the Web: a comparison of two technologies.

IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society·2000
Same author

Applying wavelet-transform on Internet-based radiologic brain images.

Computer methods and programs in biomedicine·1999
Same author

Conversion of a machine-dependent expert system into a web-based training tool.

M.D. computing : computers in medical practice·1998
Same author

Normalization of transcranial Doppler middle cerebral artery velocities after aneurysm clipping.

Surgical neurology·1997
Same author

Bilateral language representation demonstrated by language-activated SPECT and Wada test.

Neurological research·1996
Same author

MCA flow asymmetry is a marker for cerebrovascular disease.

Neurological research·1996
Same journal

Commentary.

Surgical neurology·2010
Same journal

Implant design may influence delayed heterotopic ossification after total disk arthroplasty in lumbar spine.

Surgical neurology·2010
Same journal

Addendum to "In this issue...".

Surgical neurology·2010
Same journal

Anterior interosseous syndrome vs flexor pollicis longus tendon rupture: electrodiagnosis or sonography?

Surgical neurology·2010
Same journal

Transcranial/transnasal approach for nonpituitary sellar lesions.

Surgical neurology·2010
Same journal

What will you do with the rest of your life?

Surgical neurology·2010
See all related articles

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Acute ischemic stroke management requires effective and safe therapeutic interventions.
  • Current treatment options for stroke have limitations and risks.
  • Emerging therapeutic strategies aim to improve patient outcomes and reduce complications.

Purpose of the Study:

  • To evaluate the role of thrombolytic agents in acute ischemic stroke management.
  • To compare different administration routes and agents for stroke treatment.
  • To explore potential strategies for secondary stroke prevention.

Main Methods:

  • Review of current literature on thrombolytic therapy for ischemic stroke.
  • Discussion of intravenous and intra-arterial administration of thrombolytics.

Related Experiment Videos

  • Consideration of fibrinolytic agents, low molecular weight heparins (LMWHs), and other novel therapies.

    • Main Results:

    • Intravenous thrombolysis is the most practical approach for selected acute ischemic stroke patients.
    • Intra-arterial thrombolysis offers potential advantages in specific settings.
    • Tissue plasminogen activators appear safer than streptokinase.
    • Fibrinolytic agents have unproven potential for improving stroke outcomes with reduced bleeding risk.
    • LMWHs may be more suitable for secondary stroke prevention than acute treatment.

    Conclusions:

    • Thrombolytic agents are likely to be important in managing acute ischemic stroke.
    • Optimizing administration routes and agent selection is crucial for efficacy and safety.
    • Further investigation into novel agents like monoclonal antibodies, aspirin, and ticlopidine is warranted for stroke management and prevention.